Low-grade neuroinflammation is now recognized as a mechanistic bridge between metabolic disease and cognitive dysfunction: microglial priming, cytokine spillover, and disrupted glia–neuron metabolic coupling contribute to insulin resistance, network dysconnectivity, and executive decline in diabetes [160,161]. Here, INS is linked to metabolic disease.